发明名称 Matrix metalloprotease inhibitors
摘要 Compounds of the formula (I) and their pharmaceutically acceptable salts inhibit matrix metalloproteases, such as stromelysin, gelatinase, matrilysin and collagenase, and are useful in the treatment of mammals having disease-states alleviated by the inhibition of such matrix metalloproteases.
申请公布号 US2003212067(A1) 申请公布日期 2003.11.13
申请号 US20030418012 申请日期 2003.04.16
申请人 CASTELHANO ARLINDO LUCAS;BENDER STEVEN LEE;DEAL JUDITH GAIL;HORNE STEPHEN;LIAK TENG J.;YUAN ZHENGYU 发明人 CASTELHANO ARLINDO LUCAS;BENDER STEVEN LEE;DEAL JUDITH GAIL;HORNE STEPHEN;LIAK TENG J.;YUAN ZHENGYU
分类号 C07D213/82;A61K31/16;A61K31/165;A61K31/195;A61K31/215;A61K31/235;A61K31/27;A61K31/34;A61K31/343;A61K31/38;A61K31/381;A61K31/397;A61K31/403;A61K31/404;A61K31/405;A61K31/44;A61K31/4402;A61K31/4406;A61K31/4409;A61K31/4418;A61K31/66;A61K31/662;A61K38/00;A61P1/02;A61P3/08;A61P3/10;A61P27/02;A61P29/00;A61P35/00;A61P43/00;C07C51/60;C07C53/42;C07C57/72;C07C67/313;C07C67/317;C07C69/353;C07C69/533;C07C231/02;C07C233/47;C07C237/22;C07C237/42;C07C255/57;C07C255/60;C07C259/06;C07C271/20;C07C271/22;C07C279/14;C07C311/46;C07C317/38;C07C317/40;C07C323/52;C07C323/59;C07C323/60;C07C323/63;C07C327/12;C07C327/22;C07C327/30;C07C327/32;C07D205/08;C07D209/20;C07D213/75;C07D213/80;C07D263/22;C07D263/26;C07D295/13;C07D307/91;C07D333/76;C07F9/30;C07F9/32;C07F9/34;C07F9/36;C07F9/48;C07F9/58;C07F9/60;C07F9/62;C07F9/6558;C07K5/023;(IPC1-7):A61K31/66;A61K31/537;A61K31/18 主分类号 C07D213/82
代理机构 代理人
主权项
地址